Evaluation of roscovitine anticancer agent as a reference compound for cancer and apoptosis studies
DOI:
https://doi.org/10.56511/JIPBS.2019.v6.i04.pp53-56Abstract
Apoptosis induction is a well-known strategy to mitigate the growth of cancerous cells. The aim of this study is to determine the possibility of using roscovitine as a reference agent for evaluating novel pro-apoptotic agents. This was conducted through evaluating its cytotoxic activity of roscovitine using MTT assay on HCT-116, MCF-7 and HepG2 cancer cell lines, as well as WI-38 normal cell line, and its ability to induce apoptosis by means of measuring the concentration of p53 and caspase 3 using ELISA technique. Roscovitine was found to exhibit a potent cytotoxic activity on all the cancerous cells, while normal cells was less affected after roscovitine treatment. In addition, the levels of p53 and caspase 3 in HCT-116 cell line were raised by 18.25 and 10.77 folds, respectively, following treatment with roscovitine. Thus, it was assured that roscovitine is a potent apoptosis inducing agent, and so it could be used as a reference compound in studying novel pro-apoptotic compounds
Keywords:
Apoptosis, Roscovitine, Cancer, MTT, p53 and Caspase 3Downloads
References
Galasso C, D’Aniello S, Sansone C, Ianora A, Romano G: Identification of cell death genes in sea urchin paracentrotus lividus and their expression patterns during embryonic development. Genome Biology and Evolution 2019; 11(2):586 – 96.
Iosub-Amir A, Bai F, Sohn YS, Song L, Tamir S, Marjault HB et al.: The anti-apoptotic proteins NAF-1 and iASPP interact to drive apoptosis in cancer cells. Chemical Science 2019; 10(3):665 – 73.
Grilo AL, Mantalaris A: Apoptosis: A mammalian cell bioprocessing perspective. Biotechnology Advances 2019; 37:459 – 75.
Vousden KH, Lane DP: p53 in health and disease. Nature Reviews Molecular Cell Biology 2007; 8(4):275 – 83.
Lu W, Chen L, Peng Y, Chen J: Activation of p53 by roscovitine-mediated suppression of MDM2 expression. Oncogene 2001; 20(25):3206 – 16.
Dey A, Wong ET, Cheok CF, Tergaonkar V, Lane DP: R-Roscovitine simultaneously targets both the p53 and NF- κ B pathways and causes potentiation of apoptosis: Implications in cancer therapy. Cell Death and Differentiation 2008; 15:263 – 73.
Schuler M, Green DR: Mechanisms of p53-dependent apoptosis. Biochemical Society Transactions 2001; 29(6):684 – 8.
Findley HW, Gu L, Yeager AM, Zhou M: Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood 1997; 89(8):2986 – 93.
Sawney S, Arora P, Steffi C, Chandra V, Ali M, Aggarwal KK et al.: Esculetin Induces Apoptosis in Human Leukemia Kasumi-1 cells through Caspase 3 Activation. JIPBS 2015; 2(3):273 – 89.
Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A: How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death and Differentiation 2018; 25:104 – 13.
Bach S, Knockaert M, Reinhardt J, Lozach O, Schmitt S, Baratte B et al.: Roscovitine targets, protein kinases and pyridoxal kinase. Journal of Biological Chemistry 2005; 280(35):31208 – 19.
Meijer L, Borgne A, Mulner O, Chong JPJ, Blow JJ, Inagaki N et al.: Biochemical and Cellular Effects of Roscovitine, a Potent and Selective Inhibitor of the Cyclin-Dependent Kinases cdc2, cdk2 and cdk5. European Journal of Biochemistry 1997; 243(1 – 2):527 – 36.
Ljungman M, Paulsen MT: The cyclin-dependent kinase inhibitor roscovitine inhibits RNA synthesis and triggers nuclear accumulation of p53 that is unmodified at Ser15 and Lys382. Molecular Pharmacology 2001; 60(4):785 – 9.
Slovackova J, Smarda J, Smardova J: Roscovitine-induced apoptosis of H1299 cells depends on functional status of p53. Neoplasma 2012; 56(6):606 – 12.
Mosmann T: Rapid Colorimetric Assay for Cellular Growth and Survival : Application to Proliferation and Cytotoxicity Assays. 1983; 65:55 – 63.
Nowar RM, A Osman EE, Abou-Seri SM, El Moghazy SM, Abou El Ella DA: Design, synthesis and biological evaluation of some novel quinazolinone derivatives as potent apoptotic inducers. Future Medicinal Chemistry 2018; 10(10):1191 – 205.
Abd el hameid MK, Mohammed MR: Design, synthesis, and cytotoxicity screening of 5-aryl-3-(2-(pyrrolyl) thiophenyl)-1, 2, 4-oxadiazoles as potential antitumor molecules on breast cancer MCF-7 cells. Bioorganic Chemistry 2019; 86:609 – 23.
Abd El-Meguid EA, Awad HM, Anwar MM: Synthesis of New 1,3,4Oxadiazole-benzimidazole Derivatives as Potential Antioxidants and Breast Cancer Inhibitors with Apoptosis Inducing Activity. Russian Journal of General Chemistry 2019; 89(2):348 – 56.
Abd ‐ Allah WH, Salman A, Sabry Saad S: Anticancer activity of newly synthesized 1,1 ‐ disubstituted cyclohexane ‐ 1 ‐ carboxamides: in vitro caspases mediated apoptosis activators in human cancer cell lines and their molecular modeling. Drug Development Research 2019; 1 – 15.
Published
How to Cite
Issue
Section
Copyright (c) 2019 Heba Taha, Sameh H. Mohamed, Hussein Al-Sawaf, Zeinab Hassan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at